To compare the anti-cancer effects of chalcone-9 with tamoxifen, an FDA-approved drug used for breast cancer treatment, and AG490, a selective JAK2 inhibitor frequently utilized in research, we evaluated their cytotoxic effects on breast cancer cells. This evidence concerns the gene JAK2 and breast carcinoma.